Physiological doses of cannabinoids do not adversely affect MCL viability.
Richardson
Sarah J
SJ
Widmer
Mathieu
M
Zajicek
John
J
Rule
Simon A
SA
D048588:Benzoxazines / Q000494:pharmacology; D002186:Cannabinoids / Q000494:pharmacology*; D045744:Cell Line, Tumor; D002470:Cell Survival / Q000187:drug effects; D013759:Dronabinol / Q000494:pharmacology; D006801:Humans; D020522:Lymphoma, Mantle-Cell / Q000188:drug therapy* / Q000473:pathology; D009025:Morpholines / Q000494:pharmacology; D009281:Naphthalenes / Q000494:pharmacology